Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design of Potent Inhibitors Targeting the Main Protease of SARS-CoV-2 Using QSAR Modeling, Molecular Docking, and Molecular Dynamics Simulations
Mehdi Oubahmane, Ismail Hdoufane, Christelle Delaite, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 608-608
Open Access | Times Cited: 10

Showing 10 citing articles:

Identification of potent TMPRSS4 inhibitors through structural modeling and molecular dynamics simulations
Ismail Hdoufane, Mehdi Oubahmane, Youssef Habibi, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Design, Synthesis, Molecular Modeling and Biological Evaluation of Novel Pyrazole Benzimidazolone Derivatives as Potent Antioxidants
Mohamed Adardour, Marouane Ait Lahcen, Mehdi Oubahmane, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1648-1648
Open Access | Times Cited: 10
Recent advances in chemometric modelling of inhibitors against SARS-CoV-2
Qianqian Wang, Xinyi Lu, Runqing Jia, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24209-e24209
Open Access | Times Cited: 2
Machine learning-based QSAR and LB-PaCS-MD guided design of SARS-CoV-2 main protease inhibitors
Borwornlak Toopradab, Wanting Xie, Lian Duan, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 110, pp. 129852-129852
Closed Access | Times Cited: 2
In Silico Therapeutic Study: The Next Frontier in the Fight against SARS-CoV-2 and Its Variants
Calvin R. Wei, Zarrin Basharat, Godwin C. Lang’at
Drugs and Drug Candidates (2024) Vol. 3, Iss. 1, pp. 54-69
Open Access | Times Cited: 1
Drug design of new anti-EBOV inhibitors: QSAR, homology modeling, molecular docking and molecular dynamics studies
Nouhaila Ait Lahcen, Wissal Liman, Mehdi Oubahmane, et al.
Arabian Journal of Chemistry (2024) Vol. 17, Iss. 9, pp. 105870-105870
Open Access | Times Cited: 1
Identification of promising methionine aminopeptidase enzyme inhibitors: A combine study of comprehensive virtual screening and dynamics simulation study
Alhumaidi B. Alabbas
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 9, pp. 101745-101745
Open Access | Times Cited: 4
Design of new dipeptide inhibitors against SARS-CoV 3CLpro: 3D-QSAR, molecular docking, MD simulation, ADMET studies and retrosynthesis strategy
Esslali Soukaina, Liman Wissal, Yassine Koubi, et al.
Arabian Journal of Chemistry (2023) Vol. 17, Iss. 2, pp. 105584-105584
Open Access | Times Cited: 2
Identifying Potential Human Monoacylglycerol Lipase Inhibitors from the Phytoconstituents of Morinda Citrifolia L. Fruits by in silico Pharmacology and in vitro Study
Asman Sadino, Nyi Mekar Saptarini, Jutti Levita, et al.
Journal of Experimental Pharmacology (2024) Vol. Volume 16, pp. 295-309
Open Access
Computational design of potent dimeric phenylthiazole NS5A inhibitors for hepatitis C virus
Wissal Liman, Mehdi Oubahmane, Nouhaila Ait Lahcen, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Page 1

Scroll to top